<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="43495">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01850225</url>
  </required_header>
  <id_info>
    <org_study_id>Ped ABI</org_study_id>
    <nct_id>NCT01850225</nct_id>
  </id_info>
  <brief_title>Feasibility Study of Auditory Brainstem Implant in Young Children</brief_title>
  <official_title>A Feasibility Study of the Placement, Use, and Safety of the Nucleus 24 Auditory Brainstem Implant in Non-Neurofibromatosis Type 2 (NF2) Pediatric Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>House Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>House Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital Los Angeles</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>House Research Institute</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Current treatment options for bilateral profoundly deaf children, diagnosed with inner ear
      anatomical abnormalities are limited, and in the case of absent cochleas, non-existent.  An
      auditory brainstem implant (ABI) places an electrode close to the auditory nucleus in the
      brainstem.  Children aged 2 - 5 who are not candidates for a cochlear implant, or who did
      not demonstrate benefit from a cochlear implant, will be implanted with an ABI and followed
      for 1 year for safety and a total of 3 years for preliminary efficacy.  This is a
      feasibility study to determine the safety of the ABI.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">September 2017</completion_date>
  <primary_completion_date type="Anticipated">September 2015</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Number of Serious Adverse Events</measure>
    <time_frame>12-month post-activation</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Count of the number of expected serious adverse events must not exceed that known to occur in pediatric retrosigmoid craniotomy and Count of the number of unexpected serious adverse events must not exceed 2 in the first 5 children.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Access to sound at a level (dB) and within the frequency range (500-4000 Hz), known to be associated with speech</measure>
    <time_frame>3 years post-activation</time_frame>
    <safety_issue>No</safety_issue>
    <description>ability to detect sounds</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Bilateral Cochlear Aplasia</condition>
  <condition>Bilateral Cochlear Nerve Deficiency</condition>
  <condition>Bilateral Cochlear Ossification Secondary to Meningitis</condition>
  <arm_group>
    <arm_group_label>Device implantation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Implantation of device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Auditory brainstem implant</intervention_name>
    <arm_group_label>Device implantation</arm_group_label>
    <other_name>Cochlear Corporation Nucleus 24</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Bilateral profound deafness due to cochlear aplasia, cochlear nerve deficiency, or
             ossification secondary to meningitis

          -  If previously received a cochlear implant, must demonstrate lack of benefit from that
             device

        Exclusion Criteria:

          -  Medical contraindication to craniotomy/intracranial surgery

          -  Severe cognitive or developmental delays
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>5 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric Wilkinson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>House Research Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Laurie Eisenberg, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>House Research Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>House Research Institute CARE Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90057</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>April 10, 2014</lastchanged_date>
  <firstreceived_date>April 24, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Meningitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
